Skip Navigation LinksHome > October 2013 - Volume 132 - Issue 4S-2 > Financial Disclosure Appendix for “Clinical Introduction to...
Plastic & Reconstructive Surgery:
doi: 10.1097/PRS.0b013e3182a0eb65
Cosmetic: Original Articles

Financial Disclosure Appendix for “Clinical Introduction to the Hyaluronic Acid Dermal Filler Using Cohesive Polydensified Matrix Technology”

Free Access
Article Outline
Collapse Box

Author Information

Received for publication June 17, 2013; accepted June 17, 2013.

Back to Top | Article Outline

EDITORS’ DISCLOSURES

Editor-in-Chief, Rod J. Rohrich, M.D.

Rod J. Rohrich, M.D., has no financial interest in any of the products, devices, or drugs mentioned in this article or Supplement.

Guest Editors Steve Fagien, M.D., and Z. Paul Lorenc, M.D.

Z. Paul Lorenc, M.D., is a consultant for Mentor, Merz Aesthetics, Medicis, and Johnson & Johnson.

Steven Fagien, M.D., is an advisory board member and investigator for Allergan, Medicis, Merz Aesthetics, and Galderma.

Back to Top | Article Outline

AUTHORS’ DISCLOSURES BY ARTICLE

Biophysical Characteristics of Hyaluronic Acid Soft-Tissue Fillers and Their Relevance to Aesthetic Applications

By Hema Sundaram, M.D., and Daniel Cassuto, M.D.

Hema Sundaram, M.D., serves as a consultant and/or clinical investigator for Allergan, Anteis, CosmoFrance, Ipsen, Medicis/Valeant, Mentor/Johnson & Johnson, Merz, Q-Med/Galderma, and Suneva.

Daniel Cassuto, M.D., serves as a consultant and/or clinical investigator for Mentor/Johnson & Johnson, Merz, Myoscience, and Q-Med/Galderma.

Merz Aesthetics provided the logistical and financial support for execution of this study. Unless stated otherwise, the soft-tissue fillers discussed in this article were purchased from commercial sources.

Back to Top | Article Outline
Molecular Weight Analyses and Enzymatic Degradation Profiles of the Soft-Tissue Fillers Belotero Balance, Restylane, and Juvéderm Ultra

By Timothy Corcoran Flynn, M.D., David H. Thompson, Ph.D., and Seok-Hee Hyun, Ph.D.

Timothy Corcoran Flynn, M.D., is a physician in private practice and a consultant for Merz and Canfield Scientific; he has received research support from Merz.

David H. Thompson, Ph.D., is a professor in the Department of Chemistry at Purdue University in West Lafayette, Indiana. He is a National Institutes of Health–supported organic materials chemist who has several research projects involving hyaluronic acid. He is also president and chief scientific officer of Pandion Laboratories, LLC.

Seok-Hee Hyun, Ph.D., is a senior research scientist for Pandion Laboratories, LLC. Pandion Laboratories has received research support from Merz.

Back to Top | Article Outline
Review of Key Belotero Balance Safety and Efficacy Trials

By Z. Paul Lorenc, M.D., Steven Fagien, M.D., Timothy C. Flynn, M.D., and Heidi A. Waldorf, M.D.

Z. Paul Lorenc, M.D., is a consultant for Mentor, Merz Aesthetics, Medicis, and Johnson & Johnson.

Steven Fagien, M.D., is an advisory board member and investigator for Allergan, Medicis, Merz Aesthetics, and Galderma.

Timothy C. Flynn, M.D., is a physician in private practice and a consultant for Merz and Canfield Scientific.

Heidi A. Waldorf, M.D., is an advisory board member, consultant, and speakers’ bureau member for Merz Aesthetics, Medicis, Allergan, Valeant, Solta, Bropelle, P&G, Johnson & Johnson, Unilever, and Kythera.

Back to Top | Article Outline
A Multicenter Study of the Safety and Effectiveness of Hyaluronic Acid with a Cohesive Polydensified Matrix for Treatment of Nasolabial Folds in Subjects with Fitzpatrick Skin Types IV, V, and VI

By Jeanine B. Downie, M.D., Pearl E. Grimes, M.D., and Valerie D. Callender, M.D.

Jeanine B. Downie, M.D., is a dermatologist in private practice in Montclair, New Jersey, with no potential conflicts to disclose.

Pearl E. Grimes, M.D., is a dermatologist in private practice in Los Angeles, California, and medical director of the Vitiligo and Pigmentation Institute of Southern California (Los Angeles, Calif.). She is also a clinical professor in dermatology at the University of California, Los Angeles. She has no potential conflicts to disclose.

Valerie D. Callender, M.D., is an associate professor of dermatology at Howard University School of Medicine (Washington, D.C.). She is also a dermatologist in private practice in the metropolitan Washington, D.C., area and director of the Callender Skin and Laser Center in Glenn Dale, Maryland. Dr. Callender is a member of the Merz Aesthetics Medical Faculty; she has received compensation from Merz Aesthetics for presentations to members of the medical community.

Merz Aesthetics supplied necessary materials for this study to investigators, including the hyaluronic acid Belotero Balance. In addition, Merz Aesthetics supported editorial development of this article.

Back to Top | Article Outline
A Problem-Oriented Approach to Nodular Complications from Hyaluronic Acid and Calcium Hydroxylapatite Fillers: Classification and Recommendations for Treatment

By Daniel Cassuto, M.D., and Hema Sundaram, M.D.

Daniel Cassuto, M.D., serves as a consultant and/or clinical investigator for Mentor/Johnson & Johnson, Merz, Myoscience, and Q-Med/Galderma.

Hema Sundaram, M.D., serves as a consultant and/or clinical investigator for Allergan, Anteis, CosmoFrance, Ipsen, Medicis/Valeant, Mentor/Johnson & Johnson, Merz, Q-Med/Galderma, and Suneva.

Back to Top | Article Outline
A Blanching Technique for Intradermal Injection of the Hyaluronic Acid Belotero

By Patrick Micheels, M.D., Didier Sarazin, M.D., Stéphanie Besse, M.D., Hema Sundaram, M.D., and Timothy C. Flynn, M.D.

Patrick Micheels, M.D., is a general practitioner in private practice in Geneva, Switzerland. He has been compensated for presentations about products manufactured by Merz Aesthetics at educational meetings in the European Community. He is also a consultant for Merz, Antéis, IBSA Pharma, Q-Med Switzerland, and Allergan. Other than his educational presentations, he has nothing to disclose that would represent a conflict of interest.

Didier Sarazin, M.D., is a histopathologist at a private laboratory in Geneva, with no potential conflicts to disclose.

Stéphanie Besse, M.D., is a radiologist in a private radiology center in Geneva, with no potential conflicts to disclose.

Hema Sundaram, M.D., is a physician in private practice in the metropolitan area of Washington, D.C.; she serves as a consultant and/or clinical investigator for Allergan, Antéis, CosmoFrance, Ipsen, Medicis/Valeant, Mentor/Johnson & Johnson, Merz, and Q-Med/Galderma.

Timothy C. Flynn, M.D., is a physician in private practice and a consultant for Merz and Allergan; he has received research support from Merz Aesthetics.

Back to Top | Article Outline
Clinical Application and Assessment of Belotero: A Roundtable Discussion

By Z. Paul Lorenc, M.D., Steven Fagien, M.D., Timothy C. Flynn, M.D., and Heidi A. Waldorf, M.D.

Z. Paul Lorenc, M.D., is a consultant for Mentor, Merz Aesthetics, Medicis, and Johnson & Johnson.

Steven Fagien, M.D., is an advisory board member and investigator for Allergan, Medicis, Merz Aesthetics, and Galderma.

Timothy C. Flynn, M.D., is a physician in private practice and a consultant for Merz and Canfield Scientific; he has received research support from Merz Aesthetics.

Heidi A. Waldorf, M.D., is an advisory board member, consultant, and speakers’ bureau member for Merz Aesthetics, Medicis, Allergan, Valeant, Solta, Bropelle, P&G, Johnson & Johnson, Unilever, and Kythera.

Back to Top | Article Outline

ACKNOWLEDGMENTS

Some authors were assisted in the development of their manuscripts by David J. Howell, Ph.D., and Mark R. Vogel, M.A., both medical communication specialists in San Francisco, Calif. Both Dr. Howell and Mr. Vogel were compensated by Medical Education Advocates for their editorial contributions.

©2013American Society of Plastic Surgeons

Login

Article Tools

Share